Precision Pore Structure Optimization of Additive Manufacturing Porous Tantalum Scaffolds for Bone Regeneration : A proof-of-concept study
Jiale Jin,Dongyu Wang,Hu Qian,Chengxin Ruan,Yiqi Yang,Dongdong Li,Guohua Wang,XiaoBo Zhu,Yihe Hu,Pengfei Lei
DOI: https://doi.org/10.1016/j.biomaterials.2024.122756
IF: 14
2024-08-19
Biomaterials
Abstract:Currently, the treatment of bone defects in arthroplasty is stillremains a challenge in clinical practice. Nonetheless, commercially available orthopaedic scaffolds have shown limited therapeutic effects for large bone defects, especially for massive, irregular defects. Additively manufactured porous tantalum, in particular, has emerged as a promising material for such scaffolds and is widely used in orthopaedics for its exceptional biocompatibility, osteoinduction, and mechanical properties. Porous tantalum has also exhibited unique advantages in personalised rapid manufacturing, which allows for the creation of customised scaffolds with complex geometric shapes for clinical applications at a low cost and high efficiency. However, studies on the effect of the pore structure of additively manufactured porous tantalum on bone regeneration have been rare. In this study, we designed and fabricated a batch of precision porous tantalum scaffolds via laser powder bed fusion (LPBF) with pore sizes of 250 μm (Ta 250), 450 μm (Ta 450), 650 μm (Ta 650), and 850 μm (Ta 850). We then performed a series of in vitro experiments and observed that all four groups showed good biocompatibility. In particular, Ta 450 demonstrated the best osteogenic performance. Afterwards, we used a rat bone defect model to determine the in vivo osteogenic effects. Based on micro-computed tomography and histology, we identified that Ta 450 exhibited the best bone ingrowth performance. Subsequently, we used sheep femur and hip defect models to further confirm the osteogenic effects of Ta 450 scaffolds. Finally, we verified the aforementioned in vitro and in vivo results via clinical application (seven patients waiting for revision total hip arthroplasty) of the Ta 450 scaffold. The clinical results confirmed that Ta 450 had satisfactory clinical outcomes up to the 12th-month follow-up. In summary, our findings indicate that 450 μm is the optimal pore size for porous tantalum scaffolds. This study may provide a new therapeutic strategy for the treatment of massive, irreparable, and protracted bone defects in arthroplasty.
engineering, biomedical,materials science, biomaterials